Liver cancer combo therapy shows promise in phase 3 trial
Disease control
Completed
This study tested whether combining two procedures—TACE (a chemo-blocking treatment) and RFA (a heat-based ablation)—works better than TACE alone for people with intermediate-stage liver cancer. 241 participants were randomly assigned to one of the two groups. The main goal was t…
Phase: PHASE3 • Sponsor: Ming Zhao • Aim: Disease control
Last updated May 14, 2026 12:03 UTC